WallStSmart
MDXG

MiMedx Group Inc

NASDAQ: MDXG · HEALTHCARE · BIOTECHNOLOGY

$3.09
-9.26% today

Updated 2026-04-29

Market cap
$458.33M
P/E ratio
9.64
P/S ratio
1.10x
EPS (TTM)
$0.32
Dividend yield
52W range
$3 – $8
Volume
1.3M

MiMedx Group Inc (MDXG) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+69.2%
Last 4 quarters
Revenue YoY growth
+27.1%
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+1.1%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+7.6%
2025-10-29
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-04$0.14+50.7%$4.76$4.75-0.2%
2025-10-29$0.15+150.0%$6.88$7.40+7.6%
2025-07-29$0.10+85.2%$6.79$6.52-4.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.09$0.14+50.7%$118.09M+27.1%
2025-09-30$0.06$0.15+150.0%$113.72M+35.3%
2025-06-30$0.05$0.10+85.2%$98.61M+13.1%
2025-03-31$0.06$0.05-9.1%$88.20M+4.1%
2024-12-31$0.08$0.07-6.7%$92.91M+7.0%
2024-09-30$0.04$0.05+25.0%$84.06M+2.9%
2024-06-30$0.08$0.12+50.0%$87.21M+7.3%
2024-03-31$0.05$0.07+40.0%$84.71M
2023-12-31$0.07$0.32+357.1%$86.83M
2023-09-30$0.05$0.06+20.0%$81.71M
2023-06-30$-0.02$-0.00+77.0%$81.26M

Frequently asked questions

Has MiMedx Group Inc beaten earnings estimates?
MiMedx Group Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +69.2% over the last 4 quarters.
How does MDXG stock react to earnings?
MDXG stock has moved an average of +1.1% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is MiMedx Group Inc's revenue growth rate?
MiMedx Group Inc reported year-over-year revenue growth of +27.1% in its most recent quarter, with EPS growing +100.0% year-over-year.